BAE Systems’ Active Inceptors Earn Certification on Gulfstream G600 and G500
3.12.2019 17:00:00 EET | Business Wire | Press release
BAE Systems reached a critical milestone today with the certification of its active inceptors for Gulfstream’s G600 and G500 aircraft. The certifications are from the Federal Aviation Administration for the G600 aircraft and European Aviation Safety Agency for the G500 aircraft. The achievement marks the second series of certifications for BAE Systems’ active sticks in civil applications, which were first certified on Gulfstream’s G500 aircraft last year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191203005196/en/
BAE Systems has been a world leader in active inceptor technology for more than 25 years. (Photo: BAE Systems, Inc.)
“Our active inceptors will provide pilots of these aircraft with increased situational awareness and enable enhanced handling to maintain a safe and stable flight of Gulfstream’s G500 and G600 aircraft,” said Ehtisham Siddiqui, vice president and general manager of Controls & Avionics Solutions at BAE Systems.
Unlike a passive system, active inceptors, which are part of the controls pilots use to fly an aircraft, have electronically controlled actuators that send tactile feedback to the pilot through the stick. The feedback is programmable for specific aircraft depending on customer requirements, and can warn pilots of impending structural or aerodynamic operating limits. One of the key benefits of active inceptors is the ability to link the pilot and co-pilot controls, so each can see and feel the other’s control inputs in real time.
BAE Systems has been a world leader in active inceptor technology for more than 25 years. The military version of the technology was originally developed for the Joint Strike Fighter program in the 1990s, achieving its first flight on the platform in 2000 and becoming the world’s first certified military active inceptor on the F-35 just six years later. That same core technology achieved a handful of other world firsts, which includes first flight on helicopters such as Blackhawk and Chinook. Today, the company’s active inceptors have flown on 12 different commercial and military aircraft around the world and have logged more than 200,000 flight hours.
BAE Systems is a premier provider of advanced and affordable controls, avionics, and power management systems for aircraft. From controlling the aircraft to keeping its engine running at peak performance, BAE Systems serves more than two million passengers each day. Every second of every day a plane safely takes off and lands because of its products.
For more information, visit: http://www.baesystems-ps.com/.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191203005196/en/
Contact information
BAE Systems
Anthony DeAngelis
Office: +1 603-885-4922
Mobile: +1 603-714-3664
anthony.deangelis@baesystems.com
Amanda Desourdis
Office: +44 (0)3300 485771
Mobile: +44 (0)7990 623358
amanda.desourdis3@baesystems.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FuzeBox AI Named Founding Co-Author of SPUR Coalition Technical Committee on Verifying AI Content Use5.10.2026 16:00:00 EEST | Press release
FuzeBox AI has been named by the SPUR Coalition, an international nonprofit of 37 news and media organizations, as one of four founding co-authors of its Evidence Profile Technical Committee, adopted Sept. 2, 2026, to draft an evidence profile for SPUR's Content Telemetry standard: a way for publishers to verify AI usage reports without depending on the reporting company's cooperation. Under SPUR's current standard, AI companies self-report their content use. A company that skips reporting leaves no record, and publishers can't check what they do receive. On July 10, 2026, FuzeBox proposed its Verified Provenance Telemetry Standard (VPTS): publishers seed content with detectable markers, then verify their appearance in AI outputs via an auditable ledger, with no change to SPUR's standard. Within 48 hours, three organizations filed related proposals: ProRata on usage magnitude, Encypher CEO Erik Svilich on the verification question FuzeBox raised, and LicenseFoundry on portable proof of
Mary Kay Introduces the K-Beauty Texture Edit5.10.2026 15:02:00 EEST | Press release
Mary Kay Inc.,the iconic beauty giant announced today the launch of the K-Beauty Texture Edit, aspecial-edition skin care collection available while supplies last. The collection builds on the momentum of the company's largest consumer-facing global brand platform, Beauty Is More Beautiful Shared™ which launched in September. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005600130/en/ Mary Kay's Special Edition K-Beauty Texture Edit is a trend-forward collection which includes three Korea-made products: the Mary Kay® Melt-In Cleansing Balm, Mary Kay® Snail Gel Face Patches and Mary Kay® Collagen Moisturizing Gel. (Image Credit: Mary Kay Inc.) Inspired by Korea's globally influential skin care and self-care philosophy designed to bring playful textures, innovative ingredients, and elevated beauty experiences, the K-Beauty Texture Editwas designed to resonate with a global cultural beauty movement captivating the next gene
GE HealthCare to Acquire SOFIE Biosciences, Establishing a 'Final Mile' Footprint for PET Radiopharmaceutical Supply in the U.S.5.10.2026 15:00:00 EEST | Press release
GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase price of $945 million paid in cash. The transaction is expected to close in the first half of 2027, subject to closing conditions, including regulatory approvals, at which time SOFIE Biosciences will become part of GE HealthCare’s PDx segment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005273717/en/ SOFIE Biosciences has 15 CMO sites across the U.S., manufacturing PET radiopharmaceutical products The acquisition of SOFIE Biosciences establishes a footprint for GE HealthCare in the time-critical ‘final mile’ of U.S. PET radiopharmaceutical supply, while also enabling PDx to participate in other high growth areas outside its own product portfolio. With a U.S. network of 15 CMO sites operating 21 cyclotrons, and a theranostics
Henkell Freixenet Strengthens Premium Dealcoholized Sparkling Wine Production with Solos' Patented Aroma Recovery System5.10.2026 14:24:00 EEST | Press release
Henkell Freixenet is expanding its premium dealcoholized sparkling wine production capabilities through the deployment of Solos Technology's patented Aroma Recovery System (ARS) at its Wiesbaden production site, the Group’s expertise centre for alcohol-free production. The installation represents a significant investment in next-generation dealcoholized sparkling wine production, helping preserve the natural aroma and sensory identity of the original wines. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261005959301/en/ Fürst von Metternich Riesling Alcohol-free on the bottling line, one of the first products in Henkell Freixenet’s portfolio developed in collaboration with Solos Technology. The project combines Henkell Freixenet's longstanding winemaking expertise with Solos' proprietary dealcoholization and patented aroma recovery technology. With 30 years of experience in producing alcohol-free sparkling wines, Henkell Fre
Croma-Pharma Expands Its Portfolio in Canada With saypha ® lips Lidocaine and Exprecell™5.10.2026 14:12:00 EEST | Press release
Croma-Pharma continues to build its portfolio in Canada, adding saypha® lips Lidocaine, a hyaluronic acid filler for lip augmentation,1 and Exprecell™, a medical device for the preparation of autologous PRP | Fluid-PRF.2 Both are distributed by Renellence, Croma's partner in Canada since 2025. The two additions reflect Croma's broader approach: pairing established hyaluronic acid expertise with autologous, regenerative technologies. Together, they give practitioners options across both aesthetic and regenerative treatment categories, from a single trusted source. "With saypha® lips Lidocaine and Exprecell™, we're giving Canadian practitioners a wider set of tools for facial aesthetics and regenerative treatments, each held to the same standard of precision and safety," said Andreas Prinz, Chief Executive Officer of Croma-Pharma GmbH. Renellence has distributed Croma's Saypha® hyaluronic acid filler range in Canada since October 2025, alongside medical education and training for Canadia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
